Advances and Challenges in Treatment De-Intensification of HPV-Associated Oropharyngeal Squamous Cell Carcinoma

被引:0
|
作者
Cao, Yilin [1 ]
Gilbert, Richard J. [4 ]
Quon, Harry [1 ,2 ,3 ]
机构
[1] Johns Hopkins Univ, Dept Radiat Oncol & Mol Radiat Sci, 401 North Broadway,Suite 1440, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ, Dept Otolaryngol Head & Neck Surg, 401 North Broadway,Suite 1440, Baltimore, MD 21287 USA
[3] Johns Hopkins Univ, Dept Oncol, 401 North Broadway,Suite 1440, Baltimore, MD 21287 USA
[4] Brown Univ, Dept Pathol & Lab Med, Warren Alpert Med Sch, Providence, RI 02912 USA
关键词
Human papillomavirus; Oropharyngeal carcinoma; Cancer treatment morbidity and mortality; Treatment de-intensification; Radiotherapy dose de-escalation; Swallow toxicity assessment; QUALITY-OF-LIFE; NECK-CANCER PATIENTS; HUMAN-PAPILLOMAVIRUS; RADIATION-THERAPY; HEAD; TRIAL; QUESTIONNAIRE; CHEMOTHERAPY; RADIOTHERAPY; VALIDATION;
D O I
10.1007/s40136-022-00425-2
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Purpose of Review Management paradigms for oropharyngeal carcinoma (OPC) have been rapidly evolving due to the recognition that cancers associated with the human papillomavirus (HPV) have a favorable prognosis. This is especially the case with radiation therapy as a principal curative modality, as it is associated with a number of significant treatment complications due to the anatomic density of the head and neck and the importance of the oropharyngeal organs in swallow function. This has consequently raised major questions as to whether management can be fundamentally de-intensified in terms of dose and volume, and thereby reduce injury to the surrounding normal tissue. Recent Findings Several phase I/II clinical trials have supported the hypothesis that early stage HPV-OPC can be effectively treated with de-intensified therapies from an oncologic perspective, although there remain many unanswered questions regarding the optimal de-escalation strategy from a toxicity perspective. Confounding these efforts remains our inability to quantify normal tissue injury and its relationship to swallow function. To date, existing tools largely quantify the degree of swallow injury with varying degrees of reproducibility and granularity. Analyses of the relationship between radiation dose and swallow outcomes have also typically been limited to the dose delivered to isolated normal structures and have not considered spatial radiation dose to the complex "systems" of organs that govern swallow function. Treatment de-intensification for HPV-associated OPC represents a rapidly advancing field where early studies suggest that oncologic efficacy for early stage cancers may not be compromised with lower radiation dose and minimally invasive surgical techniques. Generalizing this conclusion remains limited by the number of patients evaluated in clinical trials. The ability to determine if these efforts are reducing normal tissue injury and swallow function is also limited by the existing instruments used to measure injury.
引用
收藏
页码:464 / 474
页数:11
相关论文
共 50 条
  • [41] Epigenetic stratification of HPV-associated oropharyngeal squamous cell carcinoma and new therapeutic strategies
    Nakagawa, Takuya
    Matsusaka, Keisuke
    Kurokawa, Tomoya
    Hanazawa, Toyoyuki
    Califano, Joseph A.
    Kaneda, Atsushi
    CANCER SCIENCE, 2021, 112 : 1057 - 1057
  • [42] The Impact of "Close Margins" in HPV-Associated Oropharyngeal Squamous Cell Carcinoma Treated with TORS
    Calcano, Gabriela A.
    Rourk, Katelyn S.
    Routman, David M.
    O'Byrne, Jamie J.
    Chintakuntlawar, Ashish V.
    Garcia, Joaquin J.
    Price, Daniel L.
    Tasche, Kendall K.
    Moore, Eric J.
    Van Abel, Kathryn M.
    Yin, Linda X.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2025,
  • [43] Radiographic muscle invasion not a recurrence predictor in HPV-associated oropharyngeal squamous cell carcinoma
    Farzal, Zainab
    Du, Eugenie
    Yim, Eunice
    Mazul, Angela
    Zevallos, Jose P.
    Huang, Benjamin Y.
    Hackman, Trevor G.
    LARYNGOSCOPE, 2019, 129 (04): : 871 - 876
  • [44] An analysis of distant metastasis cases from HPV-associated oropharyngeal squamous cell carcinoma
    Brkic, Faris F.
    Kadletz-Wanke, Lorenz
    Kenner, Lukas
    Fuereder, Thorsten
    Jank, Bernhard
    Brunner, Markus
    Heiduschka, Gregor
    JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 2021, 49 (04) : 312 - 316
  • [45] A SEER-based analysis of trends in HPV-associated oropharyngeal squamous cell carcinoma
    Kim, Su Il
    Lee, Jung Woo
    Eun, Young-Gyu
    Lee, Young Chan
    INFECTIOUS AGENTS AND CANCER, 2024, 19 (01):
  • [46] HPV-associated Sinonasal Squamous Cell Carcinoma
    Lee, Rex H.
    van Zante, Annemieke
    Goldschmidt, Ezequiel
    El-Sayed, Ivan H.
    JOURNAL OF NEUROLOGICAL SURGERY REPORTS, 2025, 86 (01) : e1 - e3
  • [47] Treatment de-intensification strategies for HPV-driven oropharyngeal cancer: A short review
    Lahmamssi, C.
    Guy, J-B
    Benchekroun, N.
    Bouchbika, Z.
    Taoufik, N.
    Jouhadi, H.
    Sahraoui, S.
    Benider, A.
    Ben Mrad, M.
    Jmour, O.
    Bousarsar, A.
    Lan, M. L.
    Lei, Q.
    Benna, M.
    Moslemi, D.
    Vallard, A.
    Magne, N.
    CANCER RADIOTHERAPIE, 2020, 24 (03): : 258 - 266
  • [48] Phase II study of de-intensification of radiation and chemotherapy for low-risk HPV-related oropharyngeal squamous cell carcinoma.
    Chera, Bhishamjit S.
    Qaqish, Bahjat F.
    Weissler, Mark C.
    Hayes, David N.
    Shores, Carol G.
    Monroe, Alan
    Anderson, Roger F.
    Wu, Justin
    Grilley-Olson, Juneko E.
    Weiss, Jared
    Hackman, Trevor
    Zanation, Adam M.
    Mendenhall, William M.
    Amdur, Robert J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [49] Distinguishing between HPV-Associated Metastatic Anal Squamous Cell Cancer and HPV-Associated Oropharyngeal Cancer
    Sorscher, Steven
    CASE REPORTS IN PATHOLOGY, 2020, 2020